SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-21-006039
Filing Date
2021-05-24
Accepted
2021-05-24 17:04:29
Documents
1
Period of Report
2021-05-20

Document Format Files

Seq Description Document Type Size
1 CHANGES IN BENEFICIAL OWNERSHIP inva-form4_052021.html 4  
1 CHANGES IN BENEFICIAL OWNERSHIP inva-form4_052021.xml 4 3744
  Complete submission text file 0001387131-21-006039.txt   5582
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Reporting) CIK: 0001131399 (see all company filings)

State of Incorp.: X0
Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 21955901
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences